Savvy Updates, 7/25/22: GSK-126 Restores Beta Cells, SpaceX Grows Stem Cells, Trigger Finger/Carpal Tunnel Gene Variant, UnitedHealthcare $0 Insulin CoPay Only Will Affect Few, POGO BG Meter UPDATE

Experimental drug may help restore insulin-producing cells was written by Clarissa Brincat for, 22 July 2022.

In a recent study, the human epigenetics team at Monash University in Melbourne, Australia, found that the investigational drug GSK-126 can potentially restore insulin-producing beta-cells in Type 1 diabetes patients by inhibiting pancreatic EZH2.  The study appears in the Nature journal, Signal Transduction and Targeted Therapy. 

The EZH2 enzyme inhibits genes responsible for the development of insulin-producing beta-cells.

Leave a Reply

Your email address will not be published.